Ovapar Liquid
NDC Package 44911-0326-1
Package Information
Ovapar (angelica archangelica, caulophyllum thalictroides, xanthoxylum fraxineum, oophorinum (suis), apis mellifica, belladonna, lachesis mutus, magnesia phosphorica, sepia, murex purpurea) liquids May temporarily relieve painful menses and menstrual cramps.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0326.
Identification & Billing
Clinical Specifications
- ANGELICA ARCHANGELICA ROOT 3 [hp_X]/mL
- APIS MELLIFERA 12 [hp_X]/mL
- ATROPA BELLADONNA 12 [hp_X]/mL
- CAULOPHYLLUM THALICTROIDES ROOT 3 [hp_X]/mL
- HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE 15 [hp_X]/mL
- LACHESIS MUTA VENOM 12 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- SUS SCROFA OVARY 6 [hp_X]/mL
- ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL
- Allergens - [CS]
- Bee Venoms - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Standardized Insect Venom Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0326 - Ovapar
- 44911-0326-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0326 - Ovapar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0326-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Ovapar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains angelica archangelica root; apis mellifera; atropa belladonna; caulophyllum thalictroides root; hexaplex trunculus hypobranchial gland juice; lachesis muta venom; magnesium phosphate, dibasic trihydrate; sepia officinalis juice; sus scrofa ovary; zanthoxylum americanum bark as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on March 22, 2016. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911032601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.